Method for producing artificial recombinant rotavirus
a technology of rotavirus and recombinant rotavirus, which is applied in the direction of dsrna viruses, antibody medical ingredients, peptide sources, etc., can solve the problems of lag behind the rg system, high risk of rotavirus infection and rotavirus disease development in children aged 6 months to 2 years, and high production efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
example 1
nt of Reverse Genetics System for Mammalian Orthoreovirus
[0093]Mammalian orthoreovirus (MRV) has been extensively studied as a model virus of the family Reoviridae. An entirely plasmid-based reverse genetics (RG) system for MRV is the first system developed in the family Reoviridae (Non Patent Literature 3). For the purpose of improving RG systems for the family Reoviridae, it was examined whether the use of a FAST protein encoded by a group of fusogenic reoviruses and a capping enzyme encoded by vaccinia virus could enhance the efficiency of artificial recombinant virus production.
Materials and Methods
(1) Viruses
[0094]Mammalian orthoreovirus strain type 1 Lang (hereinafter referred to as “MRV T1L”) was used. MRV T1L can be purchased from ATCC (ATCC VR-230). The gene names and GenBank accession numbers of 10 individual RNA genome segments of MRV T1L are shown in Table 1.
TABLE 1Sequences of genome segments of MRV T1LGene nameGenBank ACCESSIONSEQ ID NOL1M247341L2AF3780032L3AF1298203M1...
example 2
nt of Rotavirus Reverse Genetics System
Materials and Methods
(1) Virus
[0105]Simian rotavirus strain SA11 was used. The present inventors previously determined and registered the nucleotide sequences of all 11 RNA genome segments of this virus strain. The names and GenBank accession numbers of the 11 individual RNA genome segments of the simian rotavirus strain SA11 (hereinafter referred to as “SA11”) used in the experiment below are shown in Table 2.
TABLE 2Sequences of genome segments of simian rotavirus SA11GenomeGenBankSEQ IDsegmentCoding proteinACCESSIONNOSegment 1VP1 (RNA-dependent LC17856411RNA polymerase)Segment 2VP2 (RNA-binding protein)LC17856512Segment 3VP3 (Guanylyltransferase)LC17856613Segment 4VP4 (Hemagglutinin, spike protein)LC17856714Segment 5NSP1 (Immune suppressive factor)LC17857015Segment 6VP6 (Inner capsid)LC17856816Segment 7NSP3 (Translation enhancer)LC17857217Segment 8NSP2 (NTPase)LC17857118Segment 9VP7(Outer capsid)LC17856919Segment 10NSP4 (Enterotoxin)LC1785732...
example 3
n of Artificial Recombinant Rotavirus Having a Deletion Mutation
[0115]An experiment was performed to examine the feasibility of the production of an artificial recombinant rotavirus having a partial deletion mutation in NSP1, a suppressive factor against host innate immune responses.
Materials and Methods
(1) Preparation of Plasmid Having a Deletion Mutation in NSP1 Gene
[0116]A plasmid having a mutated NSP1 gene (see FIG. 4), which had a 299-base deletion at positions 1192 to 1490 of the NSP1 gene (SEQ ID NO: 15), was prepared from pT7-NSP1SA11 as a template using KOD-Plus-Mutagenesis Kit (trade name, Toyobo) and specific primers for the gene. This plasmid (designated as pT7-NSP1SA11ΔC108) expresses an NSP1 protein having a deletion of C-terminal 108 amino acids of the native NSP1.
(2) Production of Artificial Recombinant Viruses and Confirmation of Mutation
[0117]A deletion mutant of rotavirus (rsSA11 / NSP1ΔC108) was produced in the same manner as in Example 2 except that pT7-NSP1SA11ΔC...
PUM
| Property | Measurement | Unit |
|---|---|---|
| diameter | aaaaa | aaaaa |
| size | aaaaa | aaaaa |
| basic | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 



